featured-Reporter Archive
-
January 12, 2023
Program at VUH seeks to improve medication safety
Vanderbilt Nursing and the Department of Pharmaceutical Services have teamed up to create the Medication Safety Champions program, intended to improve medication safety throughout Vanderbilt University Hospital. -
January 5, 2023
VUMC researchers upend dogma about vasopressin production
Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. -
January 5, 2023
Infectious disease expert Edwards ends storied career
Vanderbilt's Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022. -
January 5, 2023
VUMC-led COVID-19 clinical trial platform goes international
The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally. -
December 16, 2022
VUMC Announces VICTR Leadership Transition
-
December 15, 2022
Novel therapeutic target identified for chronic kidney disease
Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury. -
December 14, 2022
Surgical risk persists for patients who’ve had COVID
Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.